Clinical Outcomes in Narcolepsy and Cataplexy: An Evaluation of Reboxetine Treatment (CONCERT)

NCT03881852 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Narcolepsy
Cataplexy Narcolepsy
Excessive Sleepiness

Interventions

DRUG: AXS-12 (Reboxetine)
DRUG: Placebo

Sponsor

Axsome Therapeutics, Inc.